NCT01366599View on ClinicalTrials.gov

CV Events in Emetogenic Chemotherapy

CompletedOBSERVATIONAL
Enrollment

12,058

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
VomitingCardiovascular EventArterial Thromboembolic Event
Interventions
DRUG

HEC or MEC

Any HEC or MEC, including aprepitant

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY